Nebius Surges 6%, CoreWeave Treads Water as JPMorgan Upgrade Flags Rising Compute Pricing; IREN Slides 4%
Nebius (NBIS) rose 6% after announcing GPU price hikes of 17-21% starting Oct. 1. JPMorgan upgraded CoreWeave (CRWV) to Overweight with a $125 target, but its stock barely moved. IREN (IREN) fell 4% after Rothschild initiated coverage with a Neutral rating and $40 target, citing capital concerns.
How this was made

The 30-second read
Why it matters
Analysts see pricing strength as a catalyst, but capital needs remain a key risk for all three firms.
Market read
Divergent moves in AI infrastructure stocks underscore sector‑specific risk/reward dynamics.
What to watch
CoreWeave's upcoming at‑the‑market offering could dilute equity and offset pricing benefits.
Background
The article compares three AI‑compute providers after a JPMorgan upgrade and Nebius price‑increase announcement.
Ticker impact
JPMorgan upgraded CoreWeave to Overweight with a $125 price target, citing higher compute pricing.
Modest upside pressure; price may test $120-$125 range.
Upgrade is fresh but concerns over debt and dilution temper bullish impact.
Nebius announced 17‑21% price hikes on GPU capacity effective Oct. 1, its second increase in three months.
Further upside if pricing translates to revenue; watch for continued rally.
Pricing power is clear, but execution risk remains.
Rothschild initiated coverage of IREN with a Neutral rating and a $40 target, highlighting a capital‑gap concern.
Potential further decline toward $40 target.
Analyst view is new and aligns with recent 4% drop.
Market effects
AI infrastructure sector shows divergent reactions to pricing vs capital intensity.
U.S. AI compute stocks exhibit varied moves, influencing broader tech sentiment.
Highlights how pricing power can offset financing concerns in a high‑growth sector.
Counterpoint
Nebius's price hikes may suppress demand, risking volume decline despite short‑term rally.
Key entities
- Financial InstitutionJPMorgan Chase & Co.
Upgraded CoreWeave to Overweight.
- Research FirmRothschild & Co.
Initiated coverage of IREN with Neutral rating.


